Cargando…
Sodium butyrate and panobinostat induce apoptosis of chronic myeloid leukemia cells via multiple pathways
PURPOSE: Histone deacetylase inhibitor (HDACI) is a novel therapeutic option for cancer. However, the effects of HDACIs on chronic myeloid leukemia (CML) and the underlying mechanisms are still unknown. The aim of this study was to investigate the effect and the mechanism‐of‐action of two HDACI memb...
Autores principales: | Jia, Xiaoyuan, Zheng, Yinsuo, Guo, Yanzi, Chen, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503025/ https://www.ncbi.nlm.nih.gov/pubmed/30891950 http://dx.doi.org/10.1002/mgg3.613 |
Ejemplares similares
-
Cefminox sodium alleviates the high-fat high-sugar-fed mice's hepatic fatty accumulation via multiple pathways
por: Xiao, Leming, et al.
Publicado: (2023) -
Panobinostat and Multiple Myeloma in 2018
por: Yee, Andrew J., et al.
Publicado: (2018) -
Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway
por: Li, Yangbo, et al.
Publicado: (2021) -
Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
por: Tan, P, et al.
Publicado: (2014) -
Efficacy of Panobinostat for the Treatment of Multiple Myeloma
por: Eleutherakis-Papaiakovou, Evangelos, et al.
Publicado: (2020)